Expert Committee on Drug Dependence Thirty sixth Meeting Geneva, June 2014
|
|
- Priscilla Farmer
- 5 years ago
- Views:
Transcription
1 Expert Committee on Drug Dependence Thirty sixth Meeting Geneva, June Comments based on the review report a. Evidence on dependence and abuse potential Dependence has been demonstrated for ketamine in animal models. A limited number of cases of dependence in humans over the past 20 years have been described, but the terms are not consistently defined so it cannot be concluded that they are in fact dependence cases. Psychological factors that increase the probability of harm include, mood and anxiety conditions leading to self medication, and sensation seeking. Amongst these is a characteristic of the ketamine experience, which may be described as escape from reality. Some effects of ketamine may be due to an enhancement of dopamine activity, which may be of relevance for its euphoric, dependence producing, and psychotomimetic properties and it will appeal to substance users looking for extremes. It appears that the dissociative experience discourages some experimental users. Another reason for limited use mentioned in this study was the scarcity of the substance. No systematic studies on personality traits or other psychological factors leading to ketamine use or affecting the probability of harm were found. The most popular route of administration, when ketamine is used recreationally or experimentally, is the intranasal route, i.e. snorting the powder, or a solution from a vaporiser. Some long term users may use the intramuscular, subcutaneous or intravenous route as well. In the rave scene, oral administration by way of ketaminecontaining tablets occurs as well. The substance is difficult to synthesize and preparations are mainly used in hospitals and veterinary clinics, so illegal production is unlikely and diversion does not take place on a large scale. b. Risks to individual and society because of misuse Individual Ketamine can produce a depression of the central nervous system, resulting in hallucinations, disturbances in thinking, perceptions and in motor function. Rare cases of side effects like hypertension and lung edema have been reported in individuals who combined ketamine with other substances. Repeated use produces chronic impairments to episodic memory, which are reversible upon reduction of use. After prolonged and repeated infusion of ketamine infusions, liver injury may occur (100 hour continuous 36 th ECDD (2014), page 1
2 intravenous infusions). Standard psychometric tests did not reveal personality changes. Studies in healthy volunteers given ketamine have shown that ketamine produces a clinical syndrome with aspects that resemble key symptoms of schizophrenia, which may be experienced by the experimental or recreational substance user as an altered, psychedelic, state of mind. Substance users will not take ketamine in combination with protective agents like benzodiazepines. Moreover, compounds increasing the neurotoxic potency of ketamine might be co administered. Recreational use implies repeated exposure, whereas clinical use is mostly incidental. Long term adverse effects in long term users of ketamine have been reported, however are scarce. These included persisting impairment of attention and recall and a subtle visual anomaly (Jansen, 1990). In dependent users, use of the substance continues despite increasing apparent effects on their work or on their health. Society Information on ketamine is not routinely collected in population surveys and morbidity and mortality data collections. Public health problems have not been published during the past ten years. Levels of use in the general population, however, appear to be very low with higher levels in groups with access to the substance, such as medical and veterinarian professionals, and party drug users. Data from different studies in the USA and UK indicate that deaths due to ketamine abuse were in most cases due to acute multidrug intoxications. The WHO Uppsala Monitoring Centre (UMC) reported, out of 1277 reports from adverse effects from world wide PMS data, over a 2 year period, 25 cases of death, (2.0 %) and 1 case of sudden death (0.08%). In the EMCDDA report, a short overview of 13 reported deaths in which ketamine was involved were included. Only in 3 out of 13 fatal intoxications was ketamine solely identified (administered by injection). Two reports describe mixed drug fatalities. In the other cases, ketamine had either a minor role or there was a lack of data for proper evaluation. The conclusion of several authors cited in the critical review is that ketamine does not appear to currently pose a significant public health risk. c. Magnitude of the problem in countries (misuse, illicit production, smuggling etc) Ketamine has been misused as a hallucinogen for almost 30 years. Ketamine misuse is reported from a number of countries in Asia, Europe and North America. Misuse by medical personnel has also been reported. 36 th ECDD (2014), page 2
3 Due to the difficult synthesis of ketamine only diversion from legal sources has been observed. Levels of use in the general population appear to be very low with higher levels in groups with access to the substance, such as medical and veterinarian professionals, and party drug users.. The critical review includes cases of robberies in Mexico and France and attempted robbery of ketamine on its way from India to Kenya. Ketamine is illicitly manufactured in China, although India is also an important source of ketamine seized in the region. It is difficult to give an indication of the amount of the clandestine ketamine labs that are dismantled because often more than one illicit drug is manufactured. And not always is specified which lab makes what product. The INCB report (2012) mentions that 99% of all ketamine seizures worldwide in 2009 took place in Asia. Countries that reported seized material are China (including Hong Kong and Macao both SAR of China), Taiwan, India, Indonesia, Australia, Canada and El Salvador. Hydroxylamine hydrochloride, a precursor used in the manufacture of ketamine has been placed under national control in China in In the period , a number of clandestine ketamine laboratories were seized in Indonesia and the Philippines. Of the 72 countries responding to the WHO Questionnaire for the ECDD, 67 reported on the use of ketamine (mostly in Asia). Sixty two stated that Ketamine was currently authorized as a medical product in their country. Twenty eight respondents confirmed that ketamine was used in a harmful way and 12 reported on the extent of the harmful use. Fifty five reported that ketamine was controlled under legislation that was intended to regulate its availability. The ketamine critical review report prepared for the WHO ECDD in 2012, includes a survey on the use of ketamine among several hospitals in 4 countries in Africa (Ethiopia, Nigeria, Tanzania and Benin). Use of ketamine in anesthesia ranged between 15 to 49% of all the procedures in the surveyed hospitals. None of the hospitals reported cases of abuse or misuse. d. Need of the substance for medical (including veterinary) practice Ketamine is listed as an anesthetic both in EML 18th ed (2013) and in EMLc 4th ed (2013) and is authorized as a medicine in at least in 60 countries. Benzodiazepines are usually co administered with ketamine to reduce the occurrence of ketamine induced neurotoxicity. Ketamine hydrochloride is used as an analgesic and anaesthetic in human and veterinary medicine. Is one of the most commonly used anaesthetic agents in the developing countries (readily available, easy to use and inexpensive). In the critical review report for the 35 th ECDD, several Member States indicated that ketamine is indispensable for its indications in veterinary medicine. 36 th ECDD (2014), page 3
4 Other uses: Supplement to other anesthetics In obstetrics Adjuvant therapy of status asthmatics Immobilization Sedation Persistent hiccup Priapism Resistant bronchospasm e. Need of the substance for other purposes (e.g. industrial) No other uses and not applicable in industrial use. f. Measures taken by countries to curb misuse In 2006, the Commission on Narcotic Drugs (CND), in its resolution 49/6, and in 2007, in its resolution 50/3, called upon Member States to pay attention to the misuse of and trafficking in ketamine, in particular in East, South East Asia and South America, and to consider adopting a system of precautionary measures for use by their government agencies to facilitate the timely detection of the diversion of ketamine and controlling its use by placing ketamine on the list of substances controlled under their national legislation, where the domestic situation so requires. In its Annual Report for 2007, the International Narcotics Control Board (INCB) called on all Governments to implement Commission resolution 50/3 without delay. In its reports for 2008 and 2009 it called for the implementation of both resolutions 49/6 and 50/3. In 2008, in addition, the Board ʺdecided to request all Governments to provide it with information on the specific legal or administrative measures adopted pursuant to Commission resolution 49/6, including information on measures to control ketamineʺ. As of 1 December 2013, a total of 105 countries and territories have responded to the INCB. Of these, 63 countries and territories have already introduced an import authorization requirement for ketamine, and 57 countries and territories have introduced an export authorization requirement. 42 countries and territories do not require an import authorization and 48 do not require an export authorization. In 2009, a total of 55 Governments reported that ketamine had already been placed on the list of substances controlled under national legislation intended to regulate its availability. g. Impact if this substance is scheduled Ketamine is a widely used anesthetic and analgesic, especially in developing countries because it is easy to use and has a wide margin of safety when compared with other anesthetic agents. Fifty respondents reported that if ketamine was placed under 36 th ECDD (2014), page 4
5 international control, they would have the laboratory capacity to identify the substance. Six respondents indicated that the availability of ketamine for medical use will be affected if placed under international control. Data from the INCB and other UN bodies indicate that the vast majority of patients do not have access to controlled medications. There are many reasons for this, one of which is unduly restrictive laws and regulations in the countries. If ketamine is placed under international control, it can be assumed that its availability and accessibility will fall into the same level of other controlled medications, which would result a public health crisis. 2. Additional information to the critical review report Ketamine is also being used as an adjuvant analgesic and as an alternative analgesic in patients in palliative care. Studies indicate that Ketamine may reduce pain intensity in patients with advanced cancer and mixed pain syndromes (Mercadante, 2000; NHS, 2010). Neuropathic pain poorly responsive to titrated opioids and oral adjuvant analgesics (eg. antidepressant and/or anticonvulsant) particularly when there is abnormal pain sensitivity allodynia, hyperalgesia or hyperpathia. Complex ischaemic limb pain or phantom limb pain. Poorly controlled incident bone pain (often has a neuropathic element). Complex visceral / abdominal neuropathic pain. References: INCB. Report of the International Narcotics Control Board for 2012; Vienna: INCB, 2014 Mercadante S, Arcuri E, Tirelli W, Casuccio A. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: A randomized, double blind, crossover, double dose study. J Pain Symptom Manage 2000;20: NHS Lothian. Ketamine Palliative Care Guidelines. Available in QFjAA&url=http%3A%2F%2Fwww.palliativecareguidelines.scot.nhs.uk%2Fdocume nts%2fketaminefinal.pdf&ei=z4r0u5a7hyj_oekogdgg&usg=afqjcnfsrnmhbg mns6ytvgjt0hy0hrgy1a&bvm=bv ,d.zwu Accessed May 15, The critical review prepared in ua=1 3. Other comments or opinions Ketamine has several important medical uses and when used appropriately, it is safe, effective and affordable. Millions of patients (humans and animals) currently benefit from the legitimate use of ketamine. 36 th ECDD (2014), page 5
6 4. Expert reviewer s view on scheduling with rationale In September 2002 the WHO ECDD had a pre review on ketamine. A critical review was performed in The WHO ECDD concluded that there was no significant public health issues posed by ketamine and that international control was unnecessary. It was suggested that the drug be kept under surveillance. During its 35th meeting, the WHO Expert Committee on Drug Dependence discussed the critical review report on ketamine and concluded that this information was not sufficient to warrant scheduling. Ketamine is widely used as an anesthetic in countries with limited resources and in many is the only option to provide anesthesia in less complex and in rural health care settings. Placing ketamine under international control would negatively impact its availability and accessibility for legitimate medical and veterinary practice and create a public health crisis. Many of the countries facing problem due to abuse or illicit trade, manufacture or diversion of ketamine have already taken control measures based on the suggestion by the INCB. Other countries may review their situation and if necessary establish national control measures based on reports of abuse/diversion/illicit trafficking and need for therapeutic use rather than placing ketamine under international control. The suggestion is to keep the medicine under surveillance to detect trends and is consistent with the recommendation made by the WHO 35 th ECDD. 36 th ECDD (2014), page 6
Ketamine. Expert peer review on critical review report (1) 35 th Expert Committee on Drug Dependence, Hammamet, Tunisia June 4-8, 2012
Ketamine Expert peer review on critical review report (1) 35 th Expert Committee on Drug Dependence, Hammamet, Tunisia June 4-8, 2012 1. Comments based on the review report a. Evidence on dependence and
More informationExpert Committee on Drug Dependence Thirty sixth Meeting Geneva, June 2014
Expert Committee on Drug Dependence Thirty sixth Meeting Geneva, 16 20 June 2014 1. Comments based on the critical review report Ketamine is an anesthetic used in human and veterinary medicine. Sub anesthetic
More informationExpert Peer Review for Carfentanil
Expert Committee on Drug Dependence Thirty-ninth Meeting Geneva, 6-10 November 2017 Expert Peer Review for Carfentanil 1. Comments based on the review report a. Evidence on dependence and abuse potential
More informationName of the Substance
Name of the Substance 0. Do you have any information on the use of this substance in your country either for medical, scientific, industrial or other professional purposes, for non-medical consumption
More information39 th Expert Committee on Drug Dependence Process and recommendations
39 th Expert Committee on Drug Dependence Process and recommendations Dr Gilles Forte Essential Medicines and Health Products Department WHO role within the International Drug Conventions To recommend
More informationFurther information provided by the People s Republic of China on the proposed scheduling of ketamine
5 March 2015 English only Commission on Narcotic Drugs Fifty-eighth session Vienna, 9-17 March 2015 Item 6 (b) of the provisional agenda * Implementation of the international drug control treaties: Changes
More informationChallenges in Access to controlled medicines
Challenges in Access to controlled medicines Strengthening Pharmaceutical Systems for better access Vienna, UNODC 27 September 2017 Name of Author Function Division Country www.who.int Agenda Global landscape
More informationLaunch of the INCB Annual Reports 2015
Launch of the INCB Annual Reports 2015 Werner Sipp, INCB President 2 March 2016 1 The 3 Reports 2 Mandate of INCB Promote and monitor compliance with the 3 international drug control conventions by: Annual
More informationUNODC/HONLAF/26/CRP.1
8 September 2016 English only Twenty-sixth Meeting of the Heads of National Drug Law Enforcement Agencies, Africa Addis Ababa, 19-23 September 2016 Item 5 (c) of the provisional agenda * Best practices
More informationInternational Drug Control Conventions. Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol
18 October 2016 International Drug Control Conventions Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol Convention on Psychotropic Substances of 1971 United Nations Convention
More informationDrug Trafficking and Abuse - Impediments to development - Akira Fujino United Nations Office on Drugs and Crime (UNODC)
Drug Trafficking and Abuse - Impediments to development - Akira Fujino United Nations Office on Drugs and Crime (UNODC) Shanghai, 1909 Early days 1920s-30s Century of Drug Control BACKGROUND 19th century:
More informationLima - Peru, August 18-22, 2014
2014 GLOBAL SYNTHETIC DRUGS ASSESSMENT Amphetamine-type stimulants and new psychoactive substances Lima - Peru, August 18-22, 2014 Juan Carlos Araneda Ferrer Project Coordinator Global SMART Programme
More informationProposal for a COUNCIL IMPLEMENTING DECISION
EUROPEAN COMMISSION Brussels, 18.12.2017 COM(2017) 765 final 2017/0345 (NLE) Proposal for a COUNCIL IMPLEMENTING DECISION on subjecting the new psychoactive substance methyl 1-(2-phenylethyl)-4- [phenyl(propanoyl)amino]piperidine-4-carboxylate
More informationSubstances under Surveillance
Substances under Surveillance The following substances are under surveillance by the World Health Organization (WHO) as they are considered to have the potential to cause public health harm. For ease of
More informationWHO Expert Committee on Drug Dependence Pre-Review: Cannabis plant and resin. Expert Peer Review 2
WHO Expert Committee on Drug Dependence Pre-Review: Cannabis plant and resin Expert Peer Review 2 1. Comments based on the review report a. Evidence on dependence and abuse potential Dependence potential:
More informationWorld Drug Report 2017
World Drug Report 2017 DEMAND Global trends in estimated number of drug users and people with drug user disorders, 2006-2015 Global trends in the estimated prevalence of drug use and prevalence of people
More informationOICS INCB REPORT OF THE INTERNATIONAL NARCOTICS CONTROL BOARD STATEMENT BY MR. RAYMOND YANS, PRESIDENT,
UNITED NATIONS INTERNATIONAL NARCOTICS CONTROL BOARD INCB OICS Vienna International Centre, P.O. Box 500, A-1400 Vienna, Austria Telephone: +43-1-26060, Telefax: +43-1-26060-5867 / 5868, Telex: 135612
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-EIGHTH REGULAR SESSION November 11-13, 2015 Trujillo, Perú OEA/Ser.L/XIV.2.58 CICAD/doc.2201/15 27
More informationThe Global S.M.A.R.T. Programme: Synthetics Monitoring: Analysis, Reporting and Trends. ATS trends, programme progress and planned expansion
The Global S.M.A.R.T. Programme: Synthetics Monitoring: Analysis, Reporting and Trends ATS trends, programme progress and planned expansion Regional SMART Workshop, Bangkok, 5-6 August 2010 Beate Hammond,
More informationWHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2
WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis Expert Peer Review 2 1. Comments based on the review report a. Evidence on dependence and abuse potential Extracts
More informationInternational drug control conventions promote better health
International drug control conventions promote better health The preamble of both 1961 and 1971 Conventions refer to their scope and impact on health: The parties, Concerned with the health and welfare
More informationThe Drugs Scenario - Global, Regional and National
The Drugs Scenario - Global, Regional and National 1. The growing demand for narcotic drugs and psychotropic substances in the world is being met by an increase in their production through a proliferation
More information3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drugs and harmful use of alcohol 3.3 Ending the AIDS epidemic and
3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drugs and harmful use of alcohol 3.3 Ending the AIDS epidemic and combating hepatitis, 3.4 Prevention and treatment of
More informationIdentifying Common Ground on Public Health for UNGASS 2016:
Identifying Common Ground on Public Health for UNGASS 2016: What does a public health approach to global drug policy mean in practice? 21 April 2015, United Nations Headquarters Concept Note As momentum
More informationE/CN.7/2015/CRP.10 * * 9 December English only V (E) * The present document is reproduced in the form in which it was received.
9 December 2015 English only Commission on Narcotic Drugs Reconvened fifty-eighth session Vienna, 9-11 December 2015 Agenda item 6 Implementation of the international drug control treaties: Changes in
More information1. Background 2. The Big Picture 3. Global trends 4. Regional trends E/SE Asia 5. Effective responses
Simultaneous launches: Vienna and Bangkok 13 Sep 2011 1. Background 2. The Big Picture 3. Global trends 4. Regional trends E/SE Asia 5. Effective responses The international drug control system 1. Based
More informationReferences to Argentina Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS
References to Argentina Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES The global picture Cocaine In 2010, the regions with a
More informationInternational Drug Scheduling; Convention on Psychotropic Substances; Single Convention on
This document is scheduled to be published in the Federal Register on 08/14/2017 and available online at https://federalregister.gov/d/2017-17119, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationCND UNGASS FOLLOW UP
CND UNGASS FOLLOW UP INCB follow-up activities on Chapter 2. Operational recommendations on ensuring the availability of and access to controlled substances exclusively for medical and scientific purposes,
More informationDrug Use Around the World
Special Agents U.S. DRUG ENFORCEMENT AGENCY STAFFING AND BUDGETS 1975 2000 10000 5000 Total Employees 8000 6000 4000 3000 2000 4000 1975 1980 1985 1990 1995 2000 1000 1975 1980 1985 1990 1995 2000 Support
More informationThe causes of misuse:
The Drug Misuse The causes of misuse: Availability of drugs. A vulnerable personality. Adverse social environment. Regular drug taking play a role. Determining misuse and dependence, it is unclear whether
More informationREGIONAL HIGHLIGHTS AFRICA AMERICAS. Central America and the Caribbean. INTERNATIONAL NARCOTICS CONTROL BOARD Report 2017
REGIONAL HIGHLIGHTS AFRICA Increase in drug use: while Africa remains a key transit region for drug trafficking, the use of various types of drugs, including cocaine, opioids, amphetamine-type stimulants,
More information#KetamineIsMedicine. Ketamine Campaign Toolkit
#KetamineIsMedicine Ketamine Campaign Toolkit + Contents 01 The Importance of Ketamine 2 The Threat to Safe Anaesthesia and Surgical Care. 3 Ketamine campaign poster...4 What can you do?. 5 Tell us your
More informationReferences to Uruguay
References to Uruguay Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES The global picture Regional trends in illicit drug use South
More informationIntroduction Overview of the status quo
Introduction Whenever we learn that a government has prohibited the use or sale of certain goods, there is one thing we can be sure of - sooner or later, people willing to break the law will take advantage
More informationA substance that reduces pain and may or may not have psychoactive properties.
GLOSSARY OF TERMS AMPHETAMINE-TYPE STIMULANTS (ATS) A group of substances, mostly synthetic, with closely related chemical structure which have, to varying degrees, a stimulating effect on the central
More informationOICS INCB. Statement by Dr. Viroj Sumyai, President, International Narcotics Control Board (INCB)
UNITED NATIONS INTERNATIONAL NARCOTICS CONTROL BOARD INCB OICS Vienna International Centre, P.O. Box 500, A-1400 Vienna, Austria Telephone: +43-1-26060, Telefax: +43-1-26060-5867 / 5868 E-Mail: incb.secretariat@un.org
More informationProposal for a COUNCIL DECISION
EUROPEAN COMMISSION Brussels, 1.12.2014 COM(2014) 716 final 2014/0340 (NLE) Proposal for a COUNCIL DECISION on subjecting 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-DMAR) and 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine
More informationAuthor: Laura A Scott and Lucy Burns, National Drug and Alcohol Research Centre, University of New South Wales
EDRS april 2011 Author: Laura A Scott and Lucy Burns, National Drug and Alcohol Research Centre, University of New South Wales Suggested citation: Scott, L. A. & Burns, L. (2011). Has ecstasy peaked? A
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2106/14
More informationGlobal drug trends and sustainable development
Lau Global drug trends and sustainable development Chloé Carpentier Chief, Drug Research Section UNODC Göteborg, 15 November 2017 Global trends in estimated number of drug users and people with drug user
More informationQUESTIONNAIRE. Submission Information. Date of submission: 29 June Information for follow-up purposes. P.O. Box Dar es salaam.
Implementation of the recommendations adopted by the Twenty-sixth Meeting of Heads of National Drug Law Enforcement Agencies, Africa, held in Addis Ababa from 19 to 23 September 2016 QUESTIONNAIRE Submission
More informationEWS manual information flow alert database on NPS
EWS manual information flow alert database on NPS 2nd Annual meeting COPOLAD II: National drugs observatories Lisbon, 13-17 November 2017 Flow of information Principal objective of EWS collect and disseminate
More informationResolution 59/8 Promotion of measures to target new psychoactive substances and amphetamine-type stimulants
Resolution 59/8 Promotion of measures to target new psychoactive substances and amphetamine-type stimulants The Commission on Narcotic Drugs, Deeply concerned about the combination of the diversity of
More informationRoyal Internal Congress. Colegio Real de Panamá. Security council. Drug traffic on a worldwide scale. Joshua Harris Moderador
Royal Internal Congress Colegio Real de Panamá Security council Drug traffic on a worldwide scale Joshua Harris Moderador Gabriel Garcia Co-Moderador 5 y 6 de Octubre de 2017 1 Dear delegates, Welcome
More informationEMBARGOED UNTIL 22 JUNE PM CEST (GMT+2)
FACT SHEET ON STATISTICS AND TRENDS IN ILLICIT DRUGS Global estimates of drug use All illicit drug use Problem drug use** Annual prevalence (%)* 5.3 (3.3-7.3) 0.6 (0.3-0.9) Number of users (millions)*
More informationWORLD DRUG REPORT 2004 WORLD DRUG REPORT. presented by Thomas Pietschmann UNODC, Research and Analysis Section
WORLD DRUG REPORT 2004 presented by Thomas Pietschmann UNODC, Research and Analysis Section 1 OVERVIEW: ALL DRUGS CONSUMPTION 2 Estimates of annual prevalence of drug use at the global level in the late
More informationInternational Regulatory Environment for the Abuse Liability Evaluation
International Regulatory Environment for the Abuse Liability Evaluation Conference on Preclinical Abuse Liability Testing, October 19-20, 2006, Annapolis MD. Willem Scholten PharmD, MPA Quality Assurance
More informationLieutenant John Harless Mississippi Bureau of Narcotics
Lieutenant John Harless Mississippi Bureau of Narcotics Discuss current trends in drug abuse Increase awareness of the dangers of drug abuse Become familiar with the signs and symptoms of drug use 1 Controlled
More informationC. Asia. East and South-East Asia. 5. Abuse and treatment. 1. Major developments
REPORT OF THE INTERNATIONAL NARCOTICS CONTROL BOARD CICAD Hemispheric Plan of Action on Drugs, 2011-2015, countries in the Americas committed themselves to adopt measures to prevent the diversion of pharmaceutical
More informationEpidemiology of non medical use of prescription drugs. Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch
Epidemiology of non medical use of prescription drugs Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch Monitoring of the drug use situation: Annual reports questionnaire
More informationRecent developments in the detection of harms arising from the use of synthetic cathinonesin Europe
No conflict of interest Recent developments in the detection of harms arising from the use of synthetic cathinonesin Europe Ana Gallegos 24 September 2015 Lisbon Addictions Conference 2015 Paper session
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-THIRD REGULAR SESSION April 25-27, 2018 México D.F., México OEA/Ser.L/XIV.2.63 CICAD/doc.2377/18 25 April 2018 Original: Español MEASURES TO
More information9668/15 JV/PN/np 1 DGD2C
Council of the European Union Brussels, 9 June 2015 (OR. en) Interinstitutional File: 2014/0183 (NLE) 9668/15 CORDROGUE 42 NOTE From: To: Presidency Delegations No. Cion doc.: 16240/14 Subject: Draft Council
More informationSystematic Surveillance of Illicitly Manufactured Fentanyl Cases Initiated by Law Enforcement Steven P. Kurtz, PhD and Mance E.
Systematic Surveillance of Illicitly Manufactured Fentanyl Cases Initiated by Law Enforcement Steven P. Kurtz, PhD and Mance E. Buttram, PhD Nova Southeastern University Center for Applied Research on
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-THIRD REGULAR SESSION April 25-27, 2018 México D.F., México OEA/Ser.L/XIV.2.63 CICAD/doc.2385/18 25 April 2018 Original: English THE OPIOID
More informationEuropean Legal Database on Drugs
European Legal Database on Drugs / Reviewing legal aspects of substitution treatment at international level Prepared by the EMCDDA at the request of the Pompidou Group Secretariat EMCDDA ELDD Comparative
More informationHemispheric Report. evaluation report on Drug control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM)
ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) INTER-AMERICAN DRUG AbUSE CONTROL COMMISSION (CICAD) SECRETARIAT FOR MULTIDIMENSIONAL SECURITy (SMS) evaluation report on Drug
More informationVIET NAM. Synthetic drug trafficking situation. Overview
VIET NAM Overview Drug situation in Viet Nam is well-controlled but it still contains many unpredictable factors. Drug trafficked into Viet Nam via northwest, central, north border lines, international
More informationSUPPLY OF OPIATE RAW MATERIALS AND DEMAND FOR OPIATES FOR MEDICAL AND SCIENTIFIC PURPOSES
SUPPLY OF OPIATE RAW MATERIALS AND DEMAND FOR OPIATES FOR MEDICAL AND SCIENTIFIC PURPOSES Introduction 1. The International Narcotics Control Board (INCB), in fulfilment of the functions assigned to it
More informationWORLD DRUG REPORT 2011
WORLD DRUG REPORT 2011 EXECUTIVE SUMMARY Global developments in illicit drug consumption, production and trafficking Consumption Globally, UNODC estimates that, in 2009, between 149 and 272 million people,
More information1.6 Amphetamine-type stimulants
1.6 Amphetamine-type stimulants 1.6.1 Production Global ATS production estimated at some 48 metric tons The group of amphetamine-type stimulants (ATS) encompasses amphetamines (amphetamine, methamphetamine),
More informationWhat is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration
What is pregabalin? Pregabalin is a prescription drug used to manage a number of long-term conditions, including epilepsy, neuropathic pain and generalised anxiety disorder. Similar to benzodiazepines,
More informationInternational Narcotics Control Board. United Nations Convention against Illicit Traffic In Narcotic Drugs and Psychotropic Substances of 1988
International Narcotics Control Board FORM D United Nations Convention against Illicit Traffic In Narcotic Drugs and Psychotropic Substances of 1988 ANNUAL INFORMATION ON SUBSTANCES FREQUENTLY USED IN
More informationCocaine. Key Points 60 ILLICIT DRUG DATA REPORT
Cocaine Key Points The total weight of cocaine detected at the border in 2006 07 increased by over 600 percent. However, it is still lower than the peak detected weight recorded in 2001 02. More than half
More informationAccess to pain therapy in the UN resolutions: worldwide perspective
Access to pain therapy in the UN resolutions: worldwide perspective Elizabeth Mattfeld Drug Prevention and Health Branch The Single Convention recognizes the medical use of narcotic drugs as indispensable
More informationPart 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES
References to Brazil Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES The global picture Cocaine In 2010, the regions with a high
More informationINTERNATIONAL NARCOTICS CONTROL BOARD Annual Report Press Release No. 3
page 1 REGIONAL HIGHLIGHTS Africa A particularly worrisome development in Africa is the large-scale trafficking in cocaine. Both the number of couriers apprehended and the volume of bulk seizures of cocaine
More informationNorth Carolina, like the rest of the nation, has been experiencing
INVITED COMMENTARY The North Carolina Controlled Substances Reporting System: A Valuable Tool for Combating Prescription Drug Misuse William D. Bronson Prescription drug misuse is a growing problem that
More informationREVISED ELEMENTS - PROPOSED BY THE UNGASS BOARD TO THE CND FOR FURTHER CONSIDERATION - STATUS 4 November 2015
REVISED ELEMENTS - PROPOSED BY THE UNGASS BOARD TO THE CND FOR FURTHER CONSIDERATION - STATUS 4 November 2015 Noting the efforts made by Member States to achieve the goals set in the 2009 Political Declaration
More information1.1 Overview Evolution of the World Drug Problem
1.1 Overview 1.1.1 Evolution of the World Drug Problem Vigilance is needed to respond to year-onyear expansion in some market sectors The long-term stabilization which occurred in drug markets continued
More informationQuestionnaire for National Competent Authorities on the availability of Internationally Controlled Substances for medical and scientific purposes
Annex. Questionnaire sent in 2014 to competent national authorities of Member States on the availability of internationally controlled substances for medical and scientific purposes Questionnaire for National
More informationAlcohol, Tobacco, and Other Drugs: A Community Concern. Chapter 12
Alcohol, Tobacco, and Other Drugs: A Community Concern Chapter 12 Introduction Use, misuse, and abuse of mind-altering substances predates recorded history Chronic alcohol and other drug abuse or dependence
More informationInternational cooperation against the world drug problem. of human rights overrules the harm caused by drugs. Eradication of production and
Forum: Issue: Student Officer: Position: General Assembly International cooperation against the world drug problem Elisa Barkan President Chair of General Assembly Introduction: Drugs are an extremely
More informationEWS in the frame of the Joint Action on NSD and draft Council Decision on new psychoactive substances
EWS in the frame of the Joint Action on NSD and draft Council Decision on new psychoactive substances Roumen Sedefov, Budapest, March 2005 Synthetic drugs overview 1 EU is concerned because: widely consumed
More informationThe WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps
The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps Matteo Zignol STOP TB Department World Health Organization TB surveillance and
More informationA handful of dangerous new legal drugs has public health experts worried
Page 1 of 8 A handful of dangerous new legal drugs has public health experts worried MATTHEW SPEISER AUG. 11, 2015, 5:00 PM Over the past 20 years, the drug world has seen the rise of new psychoactive
More informationWhat Are Hallucinogens? (National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services)
What Are Hallucinogens? (National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services) Hallucinogens are a diverse group of drugs that alter perception
More informationCorporate Medical Policy
Corporate Medical Policy Intravenous Anesthetics for the Treatment of Chronic Pain File Name: Origination: Last CAP Review: Next CAP Review: Last Review: intravenous_anesthetics_for_the_treatment_of_chronic_pain
More informationResearch Paper 21/08/
Research Paper 21/08/18 20.35 D: 1. The nervous system. 2. The nervous system and drugs. 3. How do drugs effect the central nervous system. 4. Stimulants, hallucinogens, depressants and their effects on
More informationExpert consultation on improving drug statistics and strengthening the Annual Report Questionnaire (ARQ)
Expert consultation on improving drug statistics and strengthening the Annual Report Questionnaire (ARQ) UNODC Concept Note Background Strengthening the production, collection, dissemination and analysis
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-SECOND REGULAR SESSION November 28-30, 2012 San José, Costa Rica OEA/Ser.L/XIV.2.52 CICAD/doc.1979/12
More informationProposal for a COUNCIL DECISION
EUROPEAN COMMISSION Brussels, 12.1.2018 COM(2018) 31 final 2018/0011 (NLE) Proposal for a COUNCIL DECISION on the position to be adopted, on behalf of the European Union, in the sixty-first session of
More informationUniversity of Pittsburgh
Learning Objectives Participants will be able to: Associate the history of prescription drug use in America with the current trend of prescription drug abuse; Differentiate between the three most commonly
More informationDrug Consumption Rooms Worldwide
Drug Consumption Rooms Worldwide Eberhard Schatz Correlation Network International Network of Drug Consumption Rooms Introduction Overview of the current state of DCR s worldwide Presentation of the INDCR
More informationThe Global Tobacco Problem
Best Practices in Tobacco Control Policy: An Update Johanna Birckmayer, PhD, MPH Campaign for Tobacco Free Kids The Global Tobacco Problem Almost one billion men and 250 million women are daily smokers
More informationaids in asia and the pacific
HIV AIDS AND DEVELOPMENT IN ASIA AND THE PACIFIC a lengthening shadow aids in asia and the pacific World Health Organization Regional Offices for South East Asia and the Western Pacific Region 9 10 OCTOBER
More informationSeizures of ATS (excluding ecstasy ), 2010
Seizures of ATS (excluding ecstasy ), 2010 (countries and territories reporting seizures* of more than 10 kg) 9 5.1 8.7 12.9 Ghana Armenia 0.7 9.9 1 2.1 Syrian Arab Republic Korea (Republic of) Iraq Islamic
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-EIGHTH REGULAR SESSION November 11-13, 2015 Trujillo, Perú OEA/Ser.L/XIV.2.58 CICAD/doc.2207/15 6
More informationAnalgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015
Analgesia for Patients with Substance Abuse Disorders Lisa Jennings CN November 2015 Definitions n Addiction: A pattern of drug use characterised by aberrant drug-taking behaviours & the compulsive use
More informationⅠ.TRENDS IN ILLICIT DRUGS SMUGGLING 1. Summary The total number of seizures of illicit drugs *1 was 1,896 (4.9 times year on year) (highest number on
Ⅰ.TRENDS IN ILLICIT DRUGS SMUGGLING 1. Summary The total number of seizures of illicit drugs *1 was 1,896 (4.9 times year on year) (highest number on record). And the seized quantity *2 was approximately
More informationPublic Health Association of Australia: Policy-at-a-glance Pharmaceutical Drug Misuse Policy
Public Health Association of Australia: Policy-at-a-glance Pharmaceutical Drug Misuse Policy Key message: PHAA will 1. Support strategies focused primarily on preventing or delaying the onset of drug misuse,
More informationPCP. A Presentation By Jacob Gifford & Maverick Donohue
PCP A Presentation By Jacob Gifford & Maverick Donohue Phencyclidine Angel Dust Supergrass Speed Boat Tic Tac Zoom Shermans Animal Trank Black Whack Rocket Fuel Zombie The Peace Pill PCP was first introduced
More informationWHY FEMALES ARE MORE SENSITIVE TO COCAINE [Source: NIDA (National Institute on Drug Abuse)
Volume 7, Number 6 OCTOBER - DECEMBER, 2017 This newsletter is provided by the Lorain County Crime/Drug Lab discussing technical and general information dedicated to local agencies within Lorain County.
More informationTHEXANAX THREAT 1 THE XANAX THREAT. iaddiction.com
THEXANAX THREAT 1 THE XANAX THREAT 3 6 9 11 SOCIETAL IMPACT OF XANAX RECREATIONAL VALUE OF XANAX THE PHYSICAL, MENTAL, AND EMOTIONAL EFFECTS OF XANAX ADDICTION AND DEPENDENCE Societal Impact of Xanax Since
More informationObjectives. What is pain? 9/27/2017. Pain: Does this Hurt? Fall 2017 Dean Fox, MD, FACP
Pain: Does this Hurt? Fall 2017 Dean Fox, MD, FACP Photo credit: http://multiple-sclerosis-research.blogspot.com/2013/10/pain-and-unemployment.html Objectives Consider personal goal of pain management
More informationTopic: GHB / Ecstasy Target Group: Grades Prepared By: Neil Wagstrom Agency: Glenwood Springs P. D.
Corbin & Associates, Inc. Lesson Plan of the Month December 2000 Topic: GHB / Ecstasy Target Group: Grades 10-12 Prepared By: Neil Wagstrom Agency: Glenwood Springs P. D. Address: 823 Blake Ave. Phone:
More informationMYANMAR. Emerging trends and concerns
MYANMAR MYANMAR Emerging trends and concerns Myanmar remains a major source of methamphetamine pills and opiates in South-East Asia, most of which are manufactured in Shan State in the eastern part of
More informationOICS INCB. Vienna, 7 November Fostering a united approach to the effective implementation of the three international drug control conventions
UNITED NATIONS INTERNATIONAL NARCOTICS CONTROL BOARD INCB OICS NATIONS UNIES ORGANE INTERNATIONAL DE CONTRÔLE DES STUPÉFIANTS Vienna International Centre, P.O. Box 500, A-1400 Vienna, Austria Telephone:
More informationDeath or Legalization; Uniform Policy on Illicit Drugs
ODUMUNC 2019 Issue Brief for The World Health Organization Death or Legalization; by Kleopatra Moditsi ODU Model United Nations Society Introduction The debate on illicit drug policy has flared up this
More information